Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
5.42 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Revenue
| 2.76 | 3.533 | -0.782 | 5.703 |
| Cost of Revenue
| 0.33 | 0.322 | 0.199 | 0.145 |
| Gross Profit
| 2.431 | 3.211 | -0.981 | 5.558 |
| Gross Profit Ratio
| 0.881 | 0.909 | 1.254 | 0.975 |
| Reseach & Development Expenses
| 33.822 | 21.945 | 12.89 | 13.477 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 |
| SG&A
| 20.115 | 13.923 | 7.928 | 10.833 |
| Other Expenses
| 0 | 0 | 0 | 0 |
| Operating Expenses
| 53.937 | 35.868 | 20.818 | 24.31 |
| Operating Income
| -51.506 | -32.657 | -21.799 | -18.752 |
| Operating Income Ratio
| -18.662 | -9.243 | 27.876 | -3.288 |
| Total Other Income Expenses Net
| 2.386 | -0.951 | -0.288 | -2.934 |
| Income Before Tax
| -49.12 | -33.608 | -23.014 | -21.355 |
| Income Before Tax Ratio
| -17.797 | -9.513 | 29.43 | -3.745 |
| Income Tax Expense
| 0.119 | -0.222 | 0.927 | 2.603 |
| Net Income
| -49.12 | -33.608 | -23.014 | -21.355 |
| Net Income Ratio
| -17.797 | -9.513 | 29.43 | -3.745 |
| EPS
| -1.48 | -2.24 | -1.13 | -1.04 |
| EPS Diluted
| -1.48 | -2.24 | -1.13 | -1.04 |
| EBITDA
| -51.219 | -32.435 | -21.618 | -15.681 |
| EBITDA Ratio
| -18.558 | -9.181 | 27.645 | -2.75 |